The India cryogenic freezers market size reached USD 19.60 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 29.60 Million by 2033, exhibiting a growth rate (CAGR) of 4.20% during 2025-2033. The increasing biomedical research, expanding biobanking applications, rising demand for vaccine storage, advancements in cryopreservation technologies, government support for healthcare infrastructure, and the growing pharmaceutical sector are some of the major factors positively impacting the India cryogenic freezers market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 19.60 Million |
Market Forecast in 2033 | USD 29.60 Million |
Market Growth Rate (2025-2033) | 4.20% |
Expansion of Vaccine and Biopharmaceutical Cold Storage Infrastructure
The Indian government and private sector players are investing in advanced cold storage solutions, including cryogenic freezers, to support vaccine development, biologic drugs, and biosimilars, which is positively influencing the India cryogenic market outlook. The COVID-19 pandemic accelerated this trend, with increased demand for ultra-low temperature freezers to store mRNA vaccines. Companies such as Godrej Appliances and Blue Star Limited are significantly expanding their cold chain offerings, integrating cryogenic storage into pharmaceutical supply chains. The rise in biosimilar production, driven by India's strong position in generic pharmaceuticals, is pushing biopharma companies to enhance cold storage infrastructure for monoclonal antibodies, recombinant proteins, and gene therapies. In addition to this, regulatory agencies, including the Central Drugs Standard Control Organization (CDSCO), are enforcing stringent storage requirements for biologics, leading to the adoption of high-performance cryogenic freezers. According to the India Brand Equity Foundation report, there are 36 significant vaccine production facilities in India, and India is a major provider to more than 150 nations. This ongoing expansion of vaccine manufacturing facilities, especially for export markets, is reinforcing the need for reliable ultra-low temperature storage solutions.
Increasing Adoption of Cryopreservation in Biobanking and Regenerative Medicine
India's biobanking sector is expanding as healthcare institutions, research centers, and pharmaceutical companies prioritize long-term biological sample preservation. Cryogenic freezers are critical for storing cells, tissues, blood, and genetic material under ultra-low temperatures to maintain viability. The demand is rising due to the growth of stem cell research, personalized medicine, and regenerative therapies. Stem cell banking is witnessing increasing investment, with companies such as LifeCell International and Cordlife Sciences India expanding cryogenic storage capacities. Furthermore, the implementation of government initiatives supporting biomedical research and funding programs for genetic studies further contribute to this trend. For instance, on March 8, 2025, the Indian Council of Medical Research (ICMR) introduced the Medical Innovations Patent Mitra initiative to strengthen India's healthcare innovation and patent ecosystem. This program offers comprehensive support for patent filings and technology transfers, aiming to enhance the impact of biomedical research and promote a self-reliant healthcare sector. Additionally, advancements in cryogenic freezer technology, such as improved insulation, automated monitoring, and temperature stability, are ensuring higher sample integrity, which is providing an impetus to India cryogenic freezer market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product type, application, and end use industry.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes tunnel freezer, IQF freezer, immersion freezer, spiral freezer, and others.
Application Insights:
A detailed breakup and analysis of the market based on the enterprise size have also been provided in the report. This includes corporate laboratories, hospitals and blood centers, universities and research institutions, and others.
End Use Industry Insights:
The report has provided a detailed breakup and analysis of the market based on the end use industry. This includes food and beverages, medical and healthcare, pharmaceuticals, chemicals, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Tunnel Freezer, IQF Freezer, Immersion Freezer, Spiral Freezer, Others |
Applications Covered | Corporate Laboratories, Hospitals, Blood Centers, Universities, Research Institutions, Others |
End Use Industries Covered | Food, Beverages, Medical, Healthcare, Pharmaceuticals, Chemicals, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: